ES8507135A1 - Procedimiento de preparar derivados benzofuran- o benzopirancar-boxamidicos - Google Patents

Procedimiento de preparar derivados benzofuran- o benzopirancar-boxamidicos

Info

Publication number
ES8507135A1
ES8507135A1 ES531121A ES531121A ES8507135A1 ES 8507135 A1 ES8507135 A1 ES 8507135A1 ES 531121 A ES531121 A ES 531121A ES 531121 A ES531121 A ES 531121A ES 8507135 A1 ES8507135 A1 ES 8507135A1
Authority
ES
Spain
Prior art keywords
benzofuran
general formula
hydrogen atom
benzopyran
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES531121A
Other languages
English (en)
Spanish (es)
Other versions
ES531121A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Publication of ES531121A0 publication Critical patent/ES531121A0/es
Publication of ES8507135A1 publication Critical patent/ES8507135A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES531121A 1983-04-08 1984-03-29 Procedimiento de preparar derivados benzofuran- o benzopirancar-boxamidicos Expired ES8507135A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58062554A JPS59186969A (ja) 1983-04-08 1983-04-08 ベンゾフラン−およびベンゾピランカルボキサミド誘導体

Publications (2)

Publication Number Publication Date
ES531121A0 ES531121A0 (es) 1985-09-01
ES8507135A1 true ES8507135A1 (es) 1985-09-01

Family

ID=13203591

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531121A Expired ES8507135A1 (es) 1983-04-08 1984-03-29 Procedimiento de preparar derivados benzofuran- o benzopirancar-boxamidicos

Country Status (8)

Country Link
US (1) US4617314A (enExample)
EP (1) EP0124783B1 (enExample)
JP (1) JPS59186969A (enExample)
KR (1) KR910002883B1 (enExample)
AT (1) ATE31307T1 (enExample)
CA (1) CA1238906A (enExample)
DE (1) DE3468024D1 (enExample)
ES (1) ES8507135A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122528A (en) * 1983-12-22 1992-06-16 Erbamont, Inc. Analgesic use of benzobicyclic carboxamides
CA1297877C (en) * 1983-12-22 1992-03-24 Daniel Lednicer Benzofurancarboxamides useful as antiemetic or antipsychotic agents
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
US5175173A (en) * 1983-12-22 1992-12-29 Sun Jung Hui Carboxamides useful as antiemetic or antipsychotic agents
SE8503055D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Piperonylcarboxamido derivatives
FR2593504B1 (fr) * 1986-01-30 1988-12-09 Ile De France Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
JPS62234083A (ja) * 1986-02-28 1987-10-14 アーバモント　インク　ディビーエイ　アドリヤ　ラボラトリーズ 鎮吐薬または精神病治療薬として有用なカルボキサミド類
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
DE3724756A1 (de) * 1987-07-25 1989-02-09 Basf Ag Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel
EP0314483A1 (en) * 1987-10-29 1989-05-03 Erbamont, Inc. Preparation of benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
US5122361A (en) * 1989-04-17 1992-06-16 Trustees Of The University Of Pennsylvania Dopamine receptor ligands and imaging agents
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH07503480A (ja) * 1992-02-06 1995-04-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ４拮抗薬としてのベンゾピラン，ベンゾチオピランおよびベンゾフラン誘導体
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
GB9317987D0 (en) * 1993-08-26 1993-10-13 Glaxo Group Ltd Chemical compounds
EP1131288A1 (en) * 1998-11-20 2001-09-12 F. Hoffmann-La Roche Ag Pyrrolidine derivatives-ccr-3 receptor antagonists
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7728155B2 (en) 2003-10-24 2010-06-01 Wyeth Llc Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
BRPI0610044A2 (pt) * 2005-04-22 2010-05-25 Wyeth Corp combinações terapêuticas para o tratamento ou prevenção de depressão
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103908548A (zh) * 2014-04-02 2014-07-09 郭卫杰 一种用于治疗躁狂抑郁性精神病的中药及其制备方法
CA3001857A1 (en) * 2015-10-14 2017-04-20 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281394A (enExample) * 1961-07-25
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
MC807A1 (fr) * 1968-07-29 1970-07-30 Soc Et Scient Et Ind De L Ile Procédé de préparation de 3-alcoxy-thianaphtene-carboxamide substituées ou non
US3860619A (en) * 1969-05-09 1975-01-14 Novo Terapeutisk Labor As Sulphonylurea derivatives
GB1358684A (en) * 1970-06-15 1974-07-03 Novo Terapeutisk Labor As Carboxylic acids
DE2152230A1 (de) * 1971-10-20 1973-04-26 Boehringer Mannheim Gmbh Blutzuckersenkende sulfonylaminopyrimidine und verfahren zu deren herstellung
US3953462A (en) * 1973-10-29 1976-04-27 Xeerox Corporation Imaging process
US4205080A (en) * 1977-07-21 1980-05-27 Shell Oil Company 2,3-Dihydro benzofuran carboxamides
EP0108986A1 (en) * 1982-11-02 1984-05-23 Hokuriku Pharmaceutical Co.,Ltd N-substituted flavone-8-carboxamides

Also Published As

Publication number Publication date
EP0124783A1 (en) 1984-11-14
ATE31307T1 (de) 1987-12-15
JPS59186969A (ja) 1984-10-23
KR840009092A (ko) 1984-12-24
CA1238906A (en) 1988-07-05
EP0124783B1 (en) 1987-12-09
JPS6119630B2 (enExample) 1986-05-17
US4617314A (en) 1986-10-14
DE3468024D1 (de) 1988-01-21
KR910002883B1 (ko) 1991-05-09
ES531121A0 (es) 1985-09-01

Similar Documents

Publication Publication Date Title
ES8507135A1 (es) Procedimiento de preparar derivados benzofuran- o benzopirancar-boxamidicos
ES8604927A1 (es) Procedimiento para la preparacion de nuevos compuestos fluoroalcoxilicos
MX9203338A (es) Nuevos derivados del oxico a_nor-esteroide-3-carboxilico.
ES8203883A1 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES8603883A1 (es) Procedimiento para preparar nuevos 2-fenil-imidazoles
DE69123286D1 (de) Verwendung von 5-HT1A Rezeptoragonisten zur Hemmung der Magensäuresekretion
ES8306125A1 (es) Un procedimiento para la preparacion de derivados de fenil- piperacina.
AR241532A1 (es) Procedimiento para preparar nuevos derivados de acido-tiazolidin-4(s)-carboxilico.
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
ES8304974A1 (es) "procedimiento para la preparacion de derivados de n-oxaciclil-alcohilpiperidina".
ES2037665T3 (es) Procedimiento para la preparacion de compuestos heterociclicos que contienen n.
ES2058177T3 (es) Nuevos derivados de alcanosulfonanilida, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
EP0233154A3 (en) Unsaturated amino-acids
UA6330A1 (uk) Спосіб одержання похідних бензаміда
PL243670A1 (en) Process for manufacturing benzamide derivatives
AR248274A1 (es) Derivados de benzotiazoles sustituidos, procedimientos para producirlos, productos intermedios para dicho procedimiento y composiciones herbicidas que los contienen.
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
ES2054980T3 (es) Compuestos para el tratamiento de la incontinencia urinaria.
ES2051674T1 (es) Derivados de benzoaxin y benzotiazin dotados de actividad cardiovascular.
ES8702906A1 (es) Procedimiento para la preparacion de 2-(piridil e imidazolil)-indoles
ES8503681A1 (es) Procedimiento de preparacion de derivados del biciclo (4.2.0.) 1,3,5-octatrieno
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
ES532056A0 (es) Un procedimiento para preparar derivados de 5-halovinil-2'-desoxiuridina.
IT1157249B (it) Procedimento per la sintesi di eteri di n-propanol-diammina
AR247197A1 (es) Procedimiento para preparacion de nuevos compuestos broncoespasmoliticos

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506